EUVIMEDEUVIMED entdecken
Crossref

Antibody–Calixarene Drug Conjugate: A General Drug Delivery Platform for Tumor-Targeted Therapy

Xueyao Wu, Shunyu Yao, Qingqing Huang, Ankang Ying, Qiushi Li, Xianghui Cao, Chun Wang, Jian Xiao, Nana Feng, Zhanzhan Zhang, Dongsheng Guo iD, Yang Liu iD

ACS Applied Materials & Interfaces · 14.08.2024 · 16 (32) · 41939-41948

DOI: 10.1021/acsami.4c09588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 02.08.2024. Verfasst von Xueyao Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Calixarenes, Immunoconjugates, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalixarenesImmunoconjugatesAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorNeoplasmsDrug Delivery SystemsMice, Inbred BALB CDrug CarriersFemaleDrug Liberation

Stichwörter der Autor:innen

antibody–drug conjugatescalixarenedrug deliveryhost–guest interactionshypoxia

Substanzen

CalixarenesImmunoconjugatesAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Nankai University, Tianjin 300071, China.
  • State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.
  • State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, China.
  • School of Medical Imaging, Tianjin Medical University, Tianjin 300203, China.

ORCID-Profile: Dongsheng Guo, Yang Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, X., Yao, S., Huang, Q., Ying, A., Li, Q., Cao, X., Wang, C., Xiao, J., Feng, N., Zhang, Z., Guo, D., & Liu, Y. (2024). Antibody–Calixarene Drug Conjugate: A General Drug Delivery Platform for Tumor-Targeted Therapy. ACS Applied Materials & Interfaces, 16(32), 41939-41948. https://doi.org/10.1021/acsami.4c09588

Vancouver

Wu X, Yao S, Huang Q, Ying A, Li Q, Cao X, et al. Antibody–Calixarene Drug Conjugate: A General Drug Delivery Platform for Tumor-Targeted Therapy. ACS Applied Materials & Interfaces. 2024;16(32):41939-41948. doi:10.1021/acsami.4c09588

BibTeX
@article{Wu2024,
  author = {Wu, Xueyao and Yao, Shunyu and Huang, Qingqing and Ying, Ankang and Li, Qiushi and Cao, Xianghui and Wang, Chun and Xiao, Jian and Feng, Nana and Zhang, Zhanzhan and Guo, Dongsheng and Liu, Yang},
  title = {Antibody–Calixarene Drug Conjugate: A General Drug Delivery Platform for Tumor-Targeted Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  volume = {16},
  number = {32},
  pages = {41939--41948},
  doi = {10.1021/acsami.4c09588}
}
Kostenlos starten →